Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

ProAssurance Ready for Deals as Insurer Expands, CEO Says

ProAssurance Corp., the insurer that announced two acquisitions today, will be “opportunistic” as it considers more deals to grow in health-care liability coverage, Chief Executive Officer Stan Starnes said.

ProAssurance must “support a whole spectrum of health-care providers from home health-care aides to neurosurgeons” and device makers, Starnes said today on a conference call with analysts. “We are attentive to every opportunity that presents itself” and “when the right ones come along, we’re in a position to move and move very quickly.”

The firm, which sells professional coverage for doctors, agreed to buy Chantilly, Virginia-based Medmarc in a $153.7 million cash deal to expand in medical technology insurance, the companies said today in a statement. Medmarc writes policies for human trials and medical devices such as artificial knees and hips.

ProAssurance also will acquire Independent Nevada Doctors Insurance Exchange, which covers physicians in that state, the Birmingham, Alabama-based company said in a separate statement today. Terms weren’t disclosed.

Standard & Poor’s affirmed its BBB rating on ProAssurance after the announcements. The Medmarc acquisition will “modestly” increase ProAssurance’s risk and may help improve the company’s offerings, the ratings firm said in a statement.

ProAssurance advanced 0.5 percent to $86.21 at 12:48 p.m. in New York.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.